1.
Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004;351:781–91.CrossrefPubMedGoogle Scholar
2.
Punnoose EA, Atwal S, Liu W, Raja R, Fine BM, Hughes BG, et al. Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib. Clin Cancer Res 2012;18:2391–401.Web of ScienceCrossrefGoogle Scholar
3.
Hofman V, Bonnetaud C, Ilie MI, Vielh P, Vignaud JM, Flejou JF, et al. Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker. Clin Cancer Res 2011;17:827–35.PubMedWeb of ScienceCrossrefGoogle Scholar
4.
Ilie M, Hofman V, Long E, Bordone O, Selva E, Washetine K, et al. Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What is the best blood substrate for personalized medicine? Ann Transl Med 2014;2:107.Google Scholar
5.
Pailler E, Oulhen M, Borget I, Remon J, Ross K, Auger N, et al. Circulating tumor cells with aberrant ALK copy number predict progression-free survival during crizotinib treatment in ALK-rearranged non-small cell lung cancer patients. Cancer Res 2017;77:2222–30.PubMedCrossrefWeb of ScienceGoogle Scholar
6.
Miyamoto DT, Zheng Y, Wittner BS, Lee RJ, Zhu H, Broderick KT, et al. RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance. Science 2015;349:1351–6.PubMedCrossrefWeb of ScienceGoogle Scholar
7.
Ilie M, Long E, Butori C, Hofman V, Coelle C, Mauro V, et al. ALK-gene rearrangement, a comparative analysis on circulating tumour cells and tumour tissue from lung adenocarcinoma patients. Ann Oncol 2012;23:2907–13.PubMedCrossrefWeb of ScienceGoogle Scholar
8.
Pailler E, Adam J, Barthelemy A, Oulhen M, Auger N, Valent A, et al. Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer. J Clin Oncol 2013;31:2273–81.Web of SciencePubMedCrossrefGoogle Scholar
9.
Ilie M, Szafer-Glusman E, Hofman V, Long-Mira E, Suttmann R, Darbonne W, et al. Expression of MET in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients. Oncotarget 2017;8:26112–21.PubMedWeb of ScienceGoogle Scholar
10.
Sundaresan TK, Sequist LV, Heymach JV, Riely GJ, Janne PA, Koch WH, et al. Detection of T790M, the acquired resistance EGFR mutation, by tumor biopsy versus noninvasive blood-based analyses. Clin Cancer Res 2016;22:1103–10.Web of ScienceCrossrefPubMedGoogle Scholar
11.
Maheswaran S, Sequist LV, Nagrath S, Ulkus L, Brannigan B, Collura CV, et al. Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med 2008;359:366–77.PubMedWeb of ScienceCrossrefGoogle Scholar
12.
Ilie M, Hofman V, Long-Mira E, Selva E, Vignaud JM, Padovani B, et al. “Sentinel” circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease. PLoS One 2014;9:e111597.CrossrefPubMedWeb of ScienceGoogle Scholar
13.
Kowalik A, Kowalewska M, Gozdz S. Current approaches for avoiding the limitations of circulating tumor cells detection methods-implications for diagnosis and treatment of patients with solid tumors. Transl Res 2017;185:58–84. e15.CrossrefPubMedWeb of ScienceGoogle Scholar
14.
Carter L, Rothwell DG, Mesquita B, Smowton C, Leong HS, Fernandez-Gutierrez F, et al. Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer. Nat Med 2017;23:114–9.CrossrefPubMedWeb of ScienceGoogle Scholar
15.
Hofman V, Ilie M, Long E, Guibert N, Selva E, Washetine K, et al. Detection of circulating tumor cells from lung cancer patients in the era of targeted therapy: promises, drawbacks and pitfalls. Curr Mol Med 2014;14:440–56.Web of ScienceCrossrefPubMedGoogle Scholar
16.
Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 2013;339:580–4.Web of SciencePubMedCrossrefGoogle Scholar
17.
Butler TP, Gullino PM. Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Res 1975;35:512–6.PubMedGoogle Scholar
18.
Meng S, Tripathy D, Frenkel EP, Shete S, Naftalis EZ, Huth JF, et al. Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res 2004;10:8152–62.CrossrefPubMedGoogle Scholar
19.
Alix-Panabieres C, Pantel K. Challenges in circulating tumour cell research. Nat Rev Cancer 2014;14:623–31.CrossrefPubMedWeb of ScienceGoogle Scholar
20.
Ignatiadis M, Lee M, Jeffrey SS. Circulating tumor cells and circulating tumor DNA: challenges and opportunities on the path to clinical utility. Clin Cancer Res 2015;21:4786–800.CrossrefWeb of SciencePubMedGoogle Scholar
21.
Qin J, Alt JR, Hunsley BA, Williams TL, Fernando MR. Stabilization of circulating tumor cells in blood using a collection device with a preservative reagent. Cancer Cell Int 2014;14:23.PubMedWeb of ScienceCrossrefGoogle Scholar
22.
Stefansson S, Adams DL, Ershler WB, Le H, Ho DH. A cell transportation solution that preserves live circulating tumor cells in patient blood samples. BMC Cancer 2016;16:300.Web of SciencePubMedCrossrefGoogle Scholar
23.
Luk AW, Ma Y, Ding PN, Young FP, Chua W, Balakrishnar B, et al. CTC-mRNA (AR-V7) analysis from blood samples – impact of blood collection tube and storage time. Int J Mol Sci 2017;18:E1047.CrossrefPubMedWeb of ScienceGoogle Scholar
24.
Hofman V, Long E, Ilie M, Bonnetaud C, Vignaud JM, Flejou JF, et al. Morphological analysis of circulating tumour cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumour cell (ISET) method. Cytopathology 2012;23:30–8.PubMedWeb of ScienceCrossrefGoogle Scholar
25.
Krebs MG, Hou JM, Sloane R, Lancashire L, Priest L, Nonaka D, et al. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches. J Thorac Oncol 2012;7:306–15.PubMedCrossrefWeb of ScienceGoogle Scholar
26.
Vona G, Sabile A, Louha M, Sitruk V, Romana S, Schutze K, et al. Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulating tumor cells. Am J Pathol 2000;156:57–63.CrossrefGoogle Scholar
27.
Das K, Dumais J, Basiaga S, Krzyzanowski GD. Carbon-13 nuclear magnetic resonance analysis of formaldehyde free preservatives. Acta Histochem 2013;115:481–6.CrossrefPubMedWeb of ScienceGoogle Scholar
28.
Norton SE, Luna KK, Lechner JM, Qin J, Fernando MR. A new blood collection device minimizes cellular DNA release during sample storage and shipping when compared to a standard device. J Clin Lab Anal 2013;27:305–11.PubMedWeb of ScienceCrossrefGoogle Scholar
29.
Warton K, Yuwono NL, Cowley MJ, McCabe MJ, So A, Ford CE. Evaluation of Streck BCT and PAXgene stabilised blood collection tubes for cell-free circulating DNA studies in plasma. Mol Diagn Ther 2017;21:563–70.CrossrefPubMedWeb of ScienceGoogle Scholar
30.
Medina Diaz I, Nocon A, Mehnert DH, Fredebohm J, Diehl F, Holtrup F. Performance of Streck cfDNA blood collection tubes for liquid biopsy testing. PLoS One 2016;11:e0166354.CrossrefWeb of SciencePubMedGoogle Scholar
31.
Parpart-Li S, Bartlett B, Popoli M, Adleff V, Tucker L, Steinberg R, et al. The effect of preservative and temperature on the analysis of circulating tumor DNA. Clin Cancer Res 2017;23:2471–7.Web of ScienceCrossrefPubMedGoogle Scholar
32.
van Dessel LF, Beije N, Helmijr JC, Vitale SR, Kraan J, Look MP, et al. Application of circulating tumor DNA in prospective clinical oncology trials – standardization of preanalytical conditions. Mol Oncol 2017;11:295–304.PubMedCrossrefWeb of ScienceGoogle Scholar
33.
Normanno N, Denis MG, Thress KS, Ratcliffe M, Reck M. Guide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancer. Oncotarget 2017;8:12501–16.Web of SciencePubMedGoogle Scholar
34.
Farace F, Massard C, Vimond N, Drusch F, Jacques N, Billiot F, et al. A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas. Br J Cancer 2011;105:847–53.CrossrefWeb of SciencePubMedGoogle Scholar
35.
Srinivasan M, Sedmak D, Jewell S. Effect of fixatives and tissue processing on the content and integrity of nucleic acids. Am J Pathol 2002;161:1961–71.CrossrefPubMedGoogle Scholar
36.
Wang J, Wei Y, Zhao S, Zhou Y, He W, Zhang Y, et al. The analysis of viability for mammalian cells treated at different temperatures and its application in cell shipment. PLoS One 2017;12:e0176120.Web of SciencePubMedCrossrefGoogle Scholar
37.
Yee SS, Lieberman DB, Blanchard T, Rader J, Zhao J, Troxel AB, et al. A novel approach for next-generation sequencing of circulating tumor cells. Mol Genet Genomic Med 2016;4:395–406.PubMedWeb of ScienceCrossrefGoogle Scholar
38.
Kang Q, Henry NL, Paoletti C, Jiang H, Vats P, Chinnaiyan AM, et al. Comparative analysis of circulating tumor DNA stability In K3EDTA, Streck, and CellSave blood collection tubes. Clin Biochem 2016;49:1354–60.PubMedCrossrefGoogle Scholar
39.
Laget S, Broncy L, Hormigos K, Dhingra DM, BenMohamed F, Capiod T, et al. Technical insights into highly sensitive isolation and molecular characterization of fixed and live circulating tumor cells for early detection of tumor invasion. PLoS One 2017;12:e0169427.PubMedWeb of ScienceCrossrefGoogle Scholar
Comments (0)